Selective HLA restriction enables the evaluation and interpretation of immunogenic breadth at comparable levels to that observed with broader HLA distribution.

Hare, Jonathan; Fiore-Gartland, Andrew; McGowan, Edward; Hunter, Eric; Gilmour, Jill; Nielsen, Morten

Hare, Jonathan; Fiore-Gartland, Andrew; McGowan, Edward; Hunter, Eric; Gilmour, Jill; Nielsen, Morten.

Afiliación

Hare J; International AIDS Vaccine Initiative, New York, New York, USA.
Fiore-Gartland A; IAVI Human Immunology Laboratory, Imperial College, London, UK.
McGowan E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Hunter E; IAVI Human Immunology Laboratory, Imperial College, London, UK.
Gilmour J; Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.
Nielsen M; Department of Infectious Disease, Imperial College, London, UK.

Proteomics ; 21(17-18): e2100121, 2021 09.

Article en En | MEDLINE | ID: mdl-34275199

Asunto(s)

Epítopos de Linfocito T; Antígeno HLA-A2; Alelos; Antígenos de Histocompatibilidad; Antígenos de Histocompatibilidad Clase I; Humanos

Palabras clave

HLA diversity; HLA frequency; immunogenic breath; predicted T-cell epitopes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígeno HLA-A2 / Epítopos de Linfocito T Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Proteomics Asunto de la revista: BIOQUIMICA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google